Pennant Group (PNTG) Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 26 2026
0mins
Should l Buy PNTG?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PNTG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PNTG
Wall Street analysts forecast PNTG stock price to rise
6 Analyst Rating
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 34.050
Low
34.00
Averages
37.60
High
40.00
Current: 34.050
Low
34.00
Averages
37.60
High
40.00
About PNTG
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Arizona, California, Colorado, Connecticut, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, Wyoming, Tennessee, Georgia and Alabama. Each of these businesses is operated by a separate, independent operating subsidiary. Its segments include home health and hospice services, and senior living services. Its home health and hospice services segment includes its home health, hospice and home care businesses. Its home health services provide care after surgery or when illness or health conditions require additional assistance. Its senior living services segment includes the operation of assisted living, independent living and memory care communities. Its independent living communities are designed for active individuals or couples.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Pennant Group Reports Strong Q4 2025 Earnings and 2026 Guidance
- Strong Financial Performance: Pennant Group reported total revenue of $947.7 million for 2025, a 36.3% increase, with adjusted EBITDA at $72.5 million, reflecting successful integration of Signature Healthcare and acquisition of over 50 locations, driving significant growth.
- Quarterly Highlights: The Home Health and Hospice segment generated $233.3 million in Q4 revenue, with admissions surging 81.3%, indicating strong market demand and laying a solid foundation for future revenue growth.
- Positive Outlook: Management projects 2026 revenue between $1.13 billion and $1.17 billion, with adjusted EBITDA of $88.5 million to $94.1 million, demonstrating confidence in the integration of newly acquired operations and expected continued profit growth.
- Robust Capital Structure: The CFO noted a net debt to adjusted EBITDA ratio of 1.7x, well below the 3.25x covenant limit, and projected operating cash flows of $45 million to $55 million, indicating strong financial health.
See More
Pennant Group (PNTG) Earnings Call Transcript
See More
Pennant Group Reports Q4 Profit Increase
- Significant Profit Growth: The Pennant Group reported a fourth-quarter profit of $8.64 million, translating to $0.24 per share, which marks a substantial increase from last year's $5.76 million and $0.16 per share, indicating improved profitability.
- Strong Adjusted Earnings: Excluding items, the company reported adjusted earnings of $12.16 million or $0.34 per share, suggesting that its core business performance exceeded market expectations, thereby boosting investor confidence.
- Revenue Surge: The company's revenue for the fourth quarter rose by 53.2% to $289.32 million from $188.89 million last year, reflecting rapid growth driven by strong market demand.
- Positive Market Outlook: With significant increases in both profit and revenue, the Pennant Group's competitive position in the industry is strengthened, likely attracting further investor interest and driving stock price appreciation.
See More
Pennant Reports Q4 2023 Earnings with Strong Growth Metrics
- Earnings Beat: Pennant's Q4 2023 Non-GAAP EPS of $0.34 exceeded expectations by $0.02, indicating a robust enhancement in profitability that strengthens market confidence.
- Significant Revenue Growth: The fourth quarter revenue reached $289.32 million, a 53.2% year-over-year increase, surpassing market expectations by $14.12 million, reflecting strong performance amid robust market demand.
- EBITDAR and EBITDA Improvement: The full-year adjusted EBITDAR was $120.9 million, up 26.2%, while Q4 reached $35.3 million, a 41.7% increase, showcasing significant operational efficiency gains.
- Optimistic 2026 Guidance: Management anticipates total revenue for 2026 to be between $1.1336 billion and $1.1718 billion, with adjusted EPS expected between $1.26 and $1.36, demonstrating confidence in future growth and clear strategic planning.
See More
Pennant Group Announces Q4 and FY 2025 Earnings Release Date
- Earnings Release Announcement: The Pennant Group expects to issue its fourth quarter and fiscal year 2025 financial results on February 25, 2026, showcasing its operational achievements in home health, hospice, and senior living services.
- Investor Webcast: The company invites current and prospective investors to join a live webcast on February 26, 2026, at 10:00 a.m. Mountain Time, where management will discuss the financial results in detail, enhancing investor relations.
- Financial Information Access: Investors can access financial and other statistical information required by SEC Regulation G through the Investor Relations section of the Pennant Group's website, ensuring transparency and compliance.
- Company Background: The Pennant Group is a holding company with independent operating subsidiaries providing healthcare services across 17 states, emphasizing the independent management and operation of each subsidiary to ensure service quality and professionalism.
See More
The Pennant Group (PNTG) Sees Stock Increase: Here's the Reason Why
Stock Performance: Shares of The Pennant Group rose 4.5% following a positive consensus 'Buy' rating from analysts, with a potential upside of over 22% based on an average price target of $34.33.
Market Sentiment: The stock's rise was influenced by comments from New York Federal Reserve President John Williams, which increased expectations for an interest rate cut, boosting market confidence amid high valuations in AI stocks.
See More
Pennant Group Reports Strong Q4 2025 Earnings and 2026 Guidance
- Strong Financial Performance: Pennant Group reported total revenue of $947.7 million for 2025, a 36.3% increase, with adjusted EBITDA at $72.5 million, reflecting successful integration of Signature Healthcare and acquisition of over 50 locations, driving significant growth.
- Quarterly Highlights: The Home Health and Hospice segment generated $233.3 million in Q4 revenue, with admissions surging 81.3%, indicating strong market demand and laying a solid foundation for future revenue growth.
- Positive Outlook: Management projects 2026 revenue between $1.13 billion and $1.17 billion, with adjusted EBITDA of $88.5 million to $94.1 million, demonstrating confidence in the integration of newly acquired operations and expected continued profit growth.
- Robust Capital Structure: The CFO noted a net debt to adjusted EBITDA ratio of 1.7x, well below the 3.25x covenant limit, and projected operating cash flows of $45 million to $55 million, indicating strong financial health.
See More
Pennant Group (PNTG) Earnings Call Transcript
See More
Pennant Group Reports Q4 Profit Increase
- Significant Profit Growth: The Pennant Group reported a fourth-quarter profit of $8.64 million, translating to $0.24 per share, which marks a substantial increase from last year's $5.76 million and $0.16 per share, indicating improved profitability.
- Strong Adjusted Earnings: Excluding items, the company reported adjusted earnings of $12.16 million or $0.34 per share, suggesting that its core business performance exceeded market expectations, thereby boosting investor confidence.
- Revenue Surge: The company's revenue for the fourth quarter rose by 53.2% to $289.32 million from $188.89 million last year, reflecting rapid growth driven by strong market demand.
- Positive Market Outlook: With significant increases in both profit and revenue, the Pennant Group's competitive position in the industry is strengthened, likely attracting further investor interest and driving stock price appreciation.
See More
Pennant Reports Q4 2023 Earnings with Strong Growth Metrics
- Earnings Beat: Pennant's Q4 2023 Non-GAAP EPS of $0.34 exceeded expectations by $0.02, indicating a robust enhancement in profitability that strengthens market confidence.
- Significant Revenue Growth: The fourth quarter revenue reached $289.32 million, a 53.2% year-over-year increase, surpassing market expectations by $14.12 million, reflecting strong performance amid robust market demand.
- EBITDAR and EBITDA Improvement: The full-year adjusted EBITDAR was $120.9 million, up 26.2%, while Q4 reached $35.3 million, a 41.7% increase, showcasing significant operational efficiency gains.
- Optimistic 2026 Guidance: Management anticipates total revenue for 2026 to be between $1.1336 billion and $1.1718 billion, with adjusted EPS expected between $1.26 and $1.36, demonstrating confidence in future growth and clear strategic planning.
See More
Pennant Group Announces Q4 and FY 2025 Earnings Release Date
- Earnings Release Announcement: The Pennant Group expects to issue its fourth quarter and fiscal year 2025 financial results on February 25, 2026, showcasing its operational achievements in home health, hospice, and senior living services.
- Investor Webcast: The company invites current and prospective investors to join a live webcast on February 26, 2026, at 10:00 a.m. Mountain Time, where management will discuss the financial results in detail, enhancing investor relations.
- Financial Information Access: Investors can access financial and other statistical information required by SEC Regulation G through the Investor Relations section of the Pennant Group's website, ensuring transparency and compliance.
- Company Background: The Pennant Group is a holding company with independent operating subsidiaries providing healthcare services across 17 states, emphasizing the independent management and operation of each subsidiary to ensure service quality and professionalism.
See More
The Pennant Group (PNTG) Sees Stock Increase: Here's the Reason Why
Stock Performance: Shares of The Pennant Group rose 4.5% following a positive consensus 'Buy' rating from analysts, with a potential upside of over 22% based on an average price target of $34.33.
Market Sentiment: The stock's rise was influenced by comments from New York Federal Reserve President John Williams, which increased expectations for an interest rate cut, boosting market confidence amid high valuations in AI stocks.
See More
